Estefanía
Pérez Lopez
Investigadora desde 2016
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (12)
2024
2023
2022
-
Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review
Advances in Rheumatology, Vol. 62, Núm. 1
2017
-
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Biology of Blood and Marrow Transplantation, Vol. 23, Núm. 1, pp. 53-59
2016
-
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
Leukemia Research, Vol. 40, pp. 1-9
-
Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD
Bone Marrow Transplantation, Vol. 51, Núm. 6, pp. 819-824
2014
-
Diagnostic utility of bone marrow examination for the assessment of patients with fever of unknown origin: A 10-year single-centre experience
Internal Medicine Journal, Vol. 44, Núm. 6, pp. 610-612
-
ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma
Annals of hematology, Vol. 93, Núm. 10, pp. 1745-1753
-
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
Bone Marrow Transplantation, Vol. 49, Núm. 5, pp. 684-690
2013
-
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
Haematologica, Vol. 98, Núm. 3, pp. 437-443
2010
-
Influence of the C677T mutation in methylenetetrahydrofolate reductase gene in venous thromboembolic disease
Angiologia, Vol. 62, Núm. 6, pp. 225-231